Form 4: Arteris VP and General Counsel Sells Shares Under Pre-Arranged Trading Plan

Paul L. Alpern, VP and General Counsel of Arteris, Inc., sold 423 shares of common stock for a weighted average price of $7.6618 per share, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), reported the sale of 423 shares of common stock.
• The transaction occurred on June 5, 2025.
• The shares were sold at a weighted average price of $7.6618, with individual sales ranging from $7.60 to $7.74.
• Following this transaction, Mr. Alpern beneficially owns 83,035 shares of Arteris common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Alpern on May 8, 2024.

Sentiment

Score: 5

Explanation: Neutral. The sale of a small number of shares by an insider under a pre-arranged 10b5-1 plan is a routine disclosure and does not typically indicate significant positive or negative sentiment about the company's prospects.

Negatives

• An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived as a slight reduction in management's direct stake in the company, though the number of shares sold (423) is very small relative to the remaining holdings (83,035).

Future Outlook

The document, an SEC Form 4, does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This SEC Form 4 filing details a routine insider stock transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in the direct ownership stake of a key executive, but given the small volume and pre-arranged nature (10b5-1 plan), it is unlikely to significantly impact investor confidence or the company's share price.

Key Dates

Recommendation

Keywords

Arteris Inc., AIP, SEC Form 4, Insider Trading, Stock Sale, Paul L. Alpern, 10b5-1 Plan, Common Stock, Corporate Officer